WBI Investments LLC Takes $2.02 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

WBI Investments LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,828 shares of the healthcare conglomerate's stock, valued at approximately $2,015,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. WealthPlan Investment Management LLC grew its stake in UnitedHealth Group by 774.0% during the 3rd quarter. WealthPlan Investment Management LLC now owns 673 shares of the healthcare conglomerate's stock valued at $339,000 after acquiring an additional 596 shares in the last quarter. Millington Financial Advisors LLC grew its stake in UnitedHealth Group by 2.7% during the 3rd quarter. Millington Financial Advisors LLC now owns 3,156 shares of the healthcare conglomerate's stock valued at $1,591,000 after acquiring an additional 82 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its stake in UnitedHealth Group by 12.3% during the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 4,305 shares of the healthcare conglomerate's stock valued at $2,308,000 after acquiring an additional 473 shares in the last quarter. NewSquare Capital LLC grew its stake in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 51 shares during the period. Finally, MGO One Seven LLC grew its stake in shares of UnitedHealth Group by 5.4% in the 3rd quarter. MGO One Seven LLC now owns 6,843 shares of the healthcare conglomerate's stock valued at $3,450,000 after buying an additional 349 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.4 %

Shares of NYSE UNH traded down $2.14 during midday trading on Wednesday, reaching $521.41. 2,299,195 shares of the stock were exchanged, compared to its average volume of 4,196,830. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The stock has a 50 day moving average price of $487.65 and a 200-day moving average price of $510.99. The company has a market capitalization of $479.90 billion, a P/E ratio of 32.11, a P/E/G ratio of 1.50 and a beta of 0.55. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm earned $6.26 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date was Friday, March 8th. UnitedHealth Group's payout ratio is 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on UNH shares. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an "overweight" rating on the stock in a report on Friday, April 5th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a "buy" rating in a report on Friday, April 19th. Truist Financial restated a "buy" rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Bank of America restated a "buy" rating and issued a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an "overweight" rating in a research report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.